All results
1 results for phase ii 16 week double blind placebo controlled parallel group randomized
-
Clinical Trials
160 subjects with autoimmune pulmonary alveolar proteinosis (aPAP) will be randomized to receive once daily treatment with inhaled molgramostim or placebo for…